Literature DB >> 28622519

Replication Catastrophe: When a Checkpoint Fails because of Exhaustion.

Luis Toledo1, Kai John Neelsen2, Jiri Lukas3.   

Abstract

Proliferating cells rely on the so-called DNA replication checkpoint to ensure orderly completion of genome duplication, and its malfunction may lead to catastrophic genome disruption, including unscheduled firing of replication origins, stalling and collapse of replication forks, massive DNA breakage, and, ultimately, cell death. Despite many years of intensive research into the molecular underpinnings of the eukaryotic replication checkpoint, the mechanisms underlying the dismal consequences of its failure remain enigmatic. A recent development offers a unifying model in which the replication checkpoint guards against global exhaustion of rate-limiting replication regulators. Here we discuss how such a mechanism can prevent catastrophic genome disruption and suggest how to harness this knowledge to advance therapeutic strategies to eliminate cancer cells that inherently proliferate under increased DNA replication stress.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ATR; CHK1; DNA damage; DNA replication; RPA; WEE1; cancer therapy; catastrophe; checkpoint

Mesh:

Substances:

Year:  2017        PMID: 28622519     DOI: 10.1016/j.molcel.2017.05.001

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  77 in total

1.  Inhibition of checkpoint kinase 1 following gemcitabine-mediated S phase arrest results in CDC7- and CDK2-dependent replication catastrophe.

Authors:  Nicholas J H Warren; Alan Eastman
Journal:  J Biol Chem       Date:  2018-12-20       Impact factor: 5.157

2.  PCNA-mediated stabilization of E3 ligase RFWD3 at the replication fork is essential for DNA replication.

Authors:  Yo-Chuen Lin; Yating Wang; Rosaline Hsu; Sumanprava Giri; Susan Wopat; Mariam K Arif; Arindam Chakraborty; Kannanganattu V Prasanth; Supriya G Prasanth
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-10       Impact factor: 11.205

3.  Rtt105 functions as a chaperone for replication protein A to preserve genome stability.

Authors:  Shuqi Li; Zhiyun Xu; Jiawei Xu; Linyu Zuo; Chuanhe Yu; Pu Zheng; Haiyun Gan; Xuezheng Wang; Longtu Li; Sushma Sharma; Andrei Chabes; Di Li; Sheng Wang; Sihao Zheng; Jinbao Li; Xuefeng Chen; Yujie Sun; Dongyi Xu; Junhong Han; Kuiming Chan; Zhi Qi; Jianxun Feng; Qing Li
Journal:  EMBO J       Date:  2018-07-31       Impact factor: 11.598

4.  Cancer mutational burden is shaped by G4 DNA, replication stress and mitochondrial dysfunction.

Authors:  Albino Bacolla; Zu Ye; Zamal Ahmed; John A Tainer
Journal:  Prog Biophys Mol Biol       Date:  2019-03-14       Impact factor: 3.667

5.  ATR function is indispensable to allow proper mammalian follicle development.

Authors:  Sarai Pacheco; Andros Maldonado-Linares; Montserrat Garcia-Caldés; Ignasi Roig
Journal:  Chromosoma       Date:  2019-09-06       Impact factor: 4.316

6.  Sequential Therapy with PARP and WEE1 Inhibitors Minimizes Toxicity while Maintaining Efficacy.

Authors:  Yong Fang; Daniel J McGrail; Chaoyang Sun; Marilyne Labrie; Xiaohua Chen; Dong Zhang; Zhenlin Ju; Christopher P Vellano; Yiling Lu; Yongsheng Li; Kang Jin Jeong; Zhiyong Ding; Jiyong Liang; Steven W Wang; Hui Dai; Sanghoon Lee; Nidhi Sahni; Imelda Mercado-Uribe; Tae-Beom Kim; Ken Chen; Shiaw-Yih Lin; Guang Peng; Shannon N Westin; Jinsong Liu; Mark J O'Connor; Timothy A Yap; Gordon B Mills
Journal:  Cancer Cell       Date:  2019-06-10       Impact factor: 31.743

7.  HLTF Promotes Fork Reversal, Limiting Replication Stress Resistance and Preventing Multiple Mechanisms of Unrestrained DNA Synthesis.

Authors:  Gongshi Bai; Chames Kermi; Henriette Stoy; Carl J Schiltz; Julien Bacal; Angela M Zaino; M Kyle Hadden; Brandt F Eichman; Massimo Lopes; Karlene A Cimprich
Journal:  Mol Cell       Date:  2020-05-21       Impact factor: 17.970

Review 8.  The molecular landscape of head and neck cancer.

Authors:  C René Leemans; Peter J F Snijders; Ruud H Brakenhoff
Journal:  Nat Rev Cancer       Date:  2018-03-02       Impact factor: 60.716

9.  WEE1 kinase inhibition reverses G2/M cell cycle checkpoint activation to sensitize cancer cells to immunotherapy.

Authors:  Lillian Sun; Ellen Moore; Rose Berman; Paul E Clavijo; Anthony Saleh; Zhong Chen; Carter Van Waes; John Davies; Jay Friedman; Clint T Allen
Journal:  Oncoimmunology       Date:  2018-07-23       Impact factor: 8.110

10.  Targeted CRISPR screening identifies PRMT5 as synthetic lethality combinatorial target with gemcitabine in pancreatic cancer cells.

Authors:  Xiaolong Wei; Jiekun Yang; Sara J Adair; Harun Ozturk; Cem Kuscu; Kyung Yong Lee; William J Kane; Patrick E O'Hara; Denis Liu; Yusuf Mert Demirlenk; Alaa Hamdi Habieb; Ebru Yilmaz; Anindya Dutta; Todd W Bauer; Mazhar Adli
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.